Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Learn where to look for flights with credit card points. Start planning your next trip and enjoy amazing travel deals!
21,145 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Tesla surprised markets with two stock splits in the early 2020s. Could a third split arrive in 2026? This guide expl...
Three legendary investors are loading up on a single AI stock that's trading at a discount to its long‑term value. Th...
Dividend-focused investors face a unique puzzle with Boeing: potential for future income vs. exposure to cyclic risk....
Healthcare costs keep rising, and the momentum isn’t slowing. This article breaks down the drivers, shows how to inve...
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...
When a top executive sells a large block of stock, investors want to know whether it signals trouble or simply person...
Investors rushed to understand why intuitive surgical stock dropped this week. This article dissects the catalysts, g...
An unexpected move by Etsy’s board member sparked questions about insider trading activity. This article breaks down ...
Looking ahead five years, a disciplined approach to income can shine. This article outlines two dependable dividend s...
Two industry leaders, two very different engines. This guide breaks down whether Amazon or Home Depot is the better s...
As Haverty prepares for its 2025 earnings release, investors seek clarity on margins, store performance, and forward ...